UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 307

Sortiert nach

Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine

The Journal of pharmacology and experimental therapeutics, 1998-05, Vol.285 (2), p.724

1998

Link zum Volltext

Verfügbarkeit prüfen

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes

American Journal of Physiology: Cell Physiology, 1993-06, Vol.264 (6), p.C1570-C1576

1993

Link zum Volltext

Verfügbarkeit prüfen

Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2893-2897

1999

Link zum Volltext

Verfügbarkeit prüfen

Angiotensinogen gene expression in 3T3-L1 cells

American Journal of Physiology: Cell Physiology, 1989-02, Vol.256 (2), p.C448-C451

1989

Link zum Volltext

Verfügbarkeit prüfen

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

Bioorganic & medicinal chemistry, 2000-01, Vol.8 (1), p.181-189

2000

Link zum Volltext

Verfügbarkeit prüfen

Role of Endothelium in Conversion of Angiotensin I to Angiotensin II in Rabbit Aorta

Hypertension (Dallas, Tex. 1979), 1984-03, Vol.6 (2, Part 1), p.216-221

1984

Link zum Volltext

Verfügbarkeit prüfen

Effects of cytochrome P-450 inhibitors on endothelium-dependent relaxation in rabbit aorta

Blood vessels, 1984, Vol.21 (5), p.223

1984

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II receptors and angiotensin II receptor antagonists

Pharmacological reviews, 1993-06, Vol.45 (2), p.205

1993

Link zum Volltext

Verfügbarkeit prüfen

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: A Potent, Orally Bioavailable CRF1 Receptor Antagonist

Journal of medicinal chemistry, 2000-02, Vol.43 (3), p.449-456

2000

Link zum Volltext

Verfügbarkeit prüfen

Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta

Hypertension (Dallas, Tex. 1979), 1984-03, Vol.6 (2_Pt_1), p.216-221

1984

Link zum Volltext

Verfügbarkeit prüfen

The Metabolic Syndrome X: Convergence of Insulin Resistence, Glucose Intolerance, Hypertension, Obesity, and Dyslipidemias--Searching for the Underlying Defects

Annals of the New York Academy of Sciences, 1999, Vol.892, p.338-338

1999

Link zum Volltext

Verfügbarkeit prüfen

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

Journal of medicinal chemistry, 2000-02, Vol.43 (3), p.449

2000

Link zum Volltext

Verfügbarkeit prüfen

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyr imidine : A corticotropin-releasing factor (hCRF1) antagonist

Bioorganic & medicinal chemistry, 2000, Vol.8 (1), p.181-189

2000

Link zum Volltext

Verfügbarkeit prüfen

Polymerase chain reaction analysis of renin in rat aortic smooth muscle

Hypertension (Dallas, Tex. 1979), 1992-06, Vol.19 (6), p.697-701

1992

Link zum Volltext

Verfügbarkeit prüfen

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes

American Journal of Physiology: Cell Physiology, 1993-06, Vol.33 (6), p.C1570-C1576

1993

Link zum Volltext

Verfügbarkeit prüfen

Angiotensinogen gene expression in 3T3-L1 cells

American Journal of Physiology: Cell Physiology, 1989, Vol.25 (2), p.C448-C451

1989

Link zum Volltext

Verfügbarkeit prüfen

Endothelium-dependent relaxation is independent of arachidonic acid release

The Journal of clinical investigation, 1988-06, Vol.81 (6), p.1795-1803

1988

Link zum Volltext

Verfügbarkeit prüfen

Indigenous African Diplomacy: An Asante Case Study

The International journal of African historical studies, 1985-01, Vol.18 (3), p.487-503

Adjaye, Joseph K.

1985

Link zum Volltext

Verfügbarkeit prüfen

Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies

Cell, 2014-09, Vol.159 (1), p.69-79

2014

Link zum Volltext

Verfügbarkeit prüfen

Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV

Science translational medicine, 2014-05, Vol.6 (236), p.236ra63

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Clinical pharmacokinetics, 2021-07, Vol.60 (7), p.835-853

2021

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1191-1200

2022

Link zum Volltext

Verfügbarkeit prüfen

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005815-e1005815

2016

Link zum Volltext

Verfügbarkeit prüfen

Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (49), p.17624-17629

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(276)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(225)
Life Sciences & Biomedicine
(209)
Humans
(196)
Biological And Medical Sciences
(103)
Male
(101)
Female
(100)
Infectious Diseases
(99)
Medical Sciences
(93)
Adult
(89)
Pharmacology & Pharmacy
(89)
Hiv Infections - Drug Therapy
(73)
Pharmacology. Drug Treatments
(73)
Microbiology
(66)
Middle Aged
(65)
Human Immunodeficiency Virus
(64)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(60)
Hiv
(55)
Immunology
(48)
Antiviral Agents
(40)
Virology
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes

Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

Angiotensinogen gene expression in 3T3-L1 cells

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist

Role of Endothelium in Conversion of Angiotensin I to Angiotensin II in Rabbit Aorta

Effects of cytochrome P-450 inhibitors on endothelium-dependent relaxation in rabbit aorta

Angiotensin II receptors and angiotensin II receptor antagonists

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: A Potent, Orally Bioavailable CRF1 Receptor Antagonist

Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta

The Metabolic Syndrome X: Convergence of Insulin Resistence, Glucose Intolerance, Hypertension, Obesity, and Dyslipidemias--Searching for the Underlying Defects

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyr imidine : A corticotropin-releasing factor (hCRF1) antagonist

Polymerase chain reaction analysis of renin in rat aortic smooth muscle

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes

Angiotensinogen gene expression in 3T3-L1 cells

Endothelium-dependent relaxation is independent of arachidonic acid release

Indigenous African Diplomacy: An Asante Case Study

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies

Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex

Suchergebnisse filtern